This study tests whether a new combination of two drugs (loncastuximab tesirine and rituximab) works better than standard chemotherapy for people with diffuse large B-cell lymphoma that has returned or not improved after initial treatment. About 440 adults will take part. The mai…
Phase: PHASE3 • Sponsor: ADC Therapeutics S.A. • Aim: Disease control
Last updated May 17, 2026 08:00 UTC